Literature DB >> 19465589

Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.

Shigeru Iwata, Kazuyoshi Saito, Kunihiro Yamaoka, Shizuyo Tsujimura, Masao Nawata, Katsunori Suzuki, Yoshiya Tanaka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19465589     DOI： 10.1093/rheumatology/kep126

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  12 in total

Review 1.  Behçet's syndrome pathophysiology and potential therapeutic targets.

Authors:  Giacomo Emmi; Elena Silvestri; Danilo Squatrito; Mario Milco D'Elios; Lucia Ciucciarelli; Domenico Prisco; Lorenzo Emmi
Journal:  Intern Emerg Med       Date:  2014-01-12       Impact factor: 3.397

Review 2.  Gastrointestinal Behçet's disease: a review.

Authors:  Wasseem Skef; Matthew J Hamilton; Thurayya Arayssi
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

3.  Development of Immunopathogenesis Strategies to Treat Behçet's Disease.

Authors:  Osman Köse
Journal:  Patholog Res Int       Date:  2012-04-03

Review 4.  Anti-TNF-alpha therapy and systemic vasculitis.

Authors:  Pierre-André Jarrot; Gilles Kaplanski
Journal:  Mediators Inflamm       Date:  2014-02-27       Impact factor: 4.711

Review 5.  Off-label uses of anti-TNF therapy in three frequent disorders: Behçet's disease, sarcoidosis, and noninfectious uveitis.

Authors:  Daniel Sánchez-Cano; José Luis Callejas-Rubio; Ricardo Ruiz-Villaverde; Raquel Ríos-Fernández; Norberto Ortego-Centeno
Journal:  Mediators Inflamm       Date:  2013-08-01       Impact factor: 4.711

6.  Polymorphisms in the tumor necrosis factor gene and susceptibility to Behcet's disease: an updated meta-analysis.

Authors:  Min Zhang; Wang-Dong Xu; Peng-Fei Wen; Yan Liang; Jie Liu; Hai-Feng Pan; Dong-Qing Ye
Journal:  Mol Vis       Date:  2013-09-12       Impact factor: 2.367

7.  Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report.

Authors:  Yue Li; Zelong Han; Xianfei Wang; Zhihui Mo; Wei Zhang; Aimin Li; Side Liu
Journal:  BMC Gastroenterol       Date:  2013-12-09       Impact factor: 3.067

Review 8.  Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?

Authors:  Duk Hwan Kim; Jae Hee Cheon
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759

9.  Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease.

Authors:  Mariko Kaji; Takayuki Kishi; Takako Miyamae; Satoru Nagata; Hisashi Yamanaka; Satoshi Fujikawa
Journal:  Case Rep Rheumatol       Date:  2015-11-02

10.  Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: A case report.

Authors:  Yong Chen; Yan Shen; Hai-Fen Ma; Jian-Fei Cai; Yan-Qin Hua; Jun Zou; Jian-Long Guan
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.